Jeffrey J. Landers

1.1k total citations
26 papers, 823 citations indexed

About

Jeffrey J. Landers is a scholar working on Immunology, Immunology and Allergy and Epidemiology. According to data from OpenAlex, Jeffrey J. Landers has authored 26 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Immunology and Allergy and 8 papers in Epidemiology. Recurrent topics in Jeffrey J. Landers's work include Food Allergy and Anaphylaxis Research (9 papers), Immunotherapy and Immune Responses (9 papers) and Allergic Rhinitis and Sensitization (6 papers). Jeffrey J. Landers is often cited by papers focused on Food Allergy and Anaphylaxis Research (9 papers), Immunotherapy and Immune Responses (9 papers) and Allergic Rhinitis and Sensitization (6 papers). Jeffrey J. Landers collaborates with scholars based in United States, United Kingdom and South Korea. Jeffrey J. Landers's co-authors include James R. Baker, Katarzyna Janczak, Anna U. Bielinska, Tarek Hamouda, Paul E. Makidon, Andrzej Myc, Jessica J. O’Konek, Zhengyi Cao, Laurie Sower and Johnny W. Peterson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Jeffrey J. Landers

26 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey J. Landers United States 17 292 284 190 133 124 26 823
D Rahman United Kingdom 12 290 1.0× 221 0.8× 159 0.8× 155 1.2× 240 1.9× 16 789
Paul E. Makidon United States 14 267 0.9× 234 0.8× 163 0.9× 102 0.8× 152 1.2× 19 739
Nicolas Rochereau France 17 566 1.9× 335 1.2× 183 1.0× 241 1.8× 109 0.9× 30 1.1k
Akhilesh Kumar Shakya United States 18 217 0.7× 272 1.0× 83 0.4× 90 0.7× 199 1.6× 33 893
Ewa Oleszycka Ireland 9 616 2.1× 349 1.2× 194 1.0× 153 1.2× 85 0.7× 14 996
Gabriela Minigo Australia 22 1.1k 3.7× 614 2.2× 217 1.1× 189 1.4× 99 0.8× 40 1.8k
Mio Mejima Japan 18 490 1.7× 716 2.5× 176 0.9× 348 2.6× 173 1.4× 27 1.6k
H. Jeffery United Kingdom 9 365 1.3× 432 1.5× 143 0.8× 143 1.1× 641 5.2× 10 1.3k
Jim Eyles United Kingdom 22 349 1.2× 588 2.1× 174 0.9× 232 1.7× 238 1.9× 52 1.2k
Adriano de Sousa Portugal 8 220 0.8× 259 0.9× 88 0.5× 77 0.6× 360 2.9× 10 708

Countries citing papers authored by Jeffrey J. Landers

Since Specialization
Citations

This map shows the geographic impact of Jeffrey J. Landers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey J. Landers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey J. Landers more than expected).

Fields of papers citing papers by Jeffrey J. Landers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey J. Landers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey J. Landers. The network helps show where Jeffrey J. Landers may publish in the future.

Co-authorship network of co-authors of Jeffrey J. Landers

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey J. Landers. A scholar is included among the top collaborators of Jeffrey J. Landers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey J. Landers. Jeffrey J. Landers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croote, Derek, Joyce J. W. Wong, Jeffrey J. Landers, et al.. (2024). Preclinical efficacy of peanut-specific IgG4 antibody therapeutic IGNX001. Journal of Allergy and Clinical Immunology. 154(5). 1241–1248.e7. 4 indexed citations
2.
Croote, Derek, Joyce Wong, Jessica Grossman, et al.. (2024). IGNX001 Abrogates Peanut-mediated Mast Cell Degranulation and Murine Anaphylaxis. Journal of Allergy and Clinical Immunology. 153(2). AB125–AB125. 1 indexed citations
3.
Farazuddin, Mohammad, Leon Friesen, Jeffrey J. Landers, et al.. (2023). Retinoic Acid Signaling Is Required for Dendritic Cell Maturation and the Induction of T Cell Immunity. ImmunoHorizons. 7(6). 480–492. 5 indexed citations
4.
Jangra, Sonia, Jeffrey J. Landers, Raveen Rathnasinghe, et al.. (2023). Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice. npj Vaccines. 8(1). 96–96. 7 indexed citations
5.
Hughes, Kevin R., Jeffrey J. Landers, Katarzyna Janczak, et al.. (2022). Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut Allergy. SHILAP Revista de lepidopterología. 3. 829605–829605. 21 indexed citations
6.
Landers, Jeffrey J., Katarzyna Janczak, Akhilesh Kumar Shakya, et al.. (2022). Targeted Allergen-Specific Immunotherapy within the Skin Improves Allergen Delivery to Induce Desensitization to Peanut. Immunotherapy. 14(7). 539–552. 20 indexed citations
7.
Landers, Jeffrey J., et al.. (2022). Differential induction of trained innate immunity following early-life immunization with aluminum adjuvant results in preferential priming of Th2-biased immune responses. Journal of Allergy and Clinical Immunology. 149(2). AB153–AB153. 2 indexed citations
8.
Farazuddin, Mohammad, Jeffrey J. Landers, Katarzyna Janczak, et al.. (2021). Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens. Frontiers in Immunology. 12. 599296–599296. 16 indexed citations
9.
Jangra, Sonia, Jeffrey J. Landers, Raveen Rathnasinghe, et al.. (2021). A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine. Frontiers in Immunology. 12. 729189–729189. 28 indexed citations
10.
Farazuddin, Mohammad, et al.. (2019). Nanoemulsion Adjuvant Augments Retinaldehyde Dehydrogenase Activity in Dendritic Cells via MyD88 Pathway. Frontiers in Immunology. 10. 916–916. 5 indexed citations
11.
Bhattacharjee, Somnath, Jesse Chen, Jeffrey J. Landers, & James R. Baker. (2019). Zwitterionic Surfactant as a Promising Non‐Cytotoxic Carrier for Nanoemulsion‐Based Vaccine Development. ChemistrySelect. 4(31). 9027–9032. 4 indexed citations
12.
O’Konek, Jessica J., Jeffrey J. Landers, Katarzyna Janczak, et al.. (2018). Nanoemulsion adjuvant–driven redirection of TH2 immunity inhibits allergic reactions in murine models of peanut allergy. Journal of Allergy and Clinical Immunology. 141(6). 2121–2131. 28 indexed citations
13.
O’Konek, Jessica J., Jeffrey J. Landers, Katarzyna Janczak, Pamela T. Wong, & James R. Baker. (2017). Adjuvant-Driven Redirection of Th2 Immunity Inhibits Allergic Reactions in Murine Models of Food Allergy. Journal of Allergy and Clinical Immunology. 139(2). AB175–AB175. 1 indexed citations
14.
O’Konek, Jessica J., Paul E. Makidon, Jeffrey J. Landers, et al.. (2015). Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton rats. Human Vaccines & Immunotherapeutics. 11(12). 2904–2912. 21 indexed citations
15.
Sitrin, Robert G., et al.. (2009). Migrating Human Neutrophils Exhibit Dynamic Spatiotemporal Variation in Membrane Lipid Organization. American Journal of Respiratory Cell and Molecular Biology. 43(4). 498–506. 20 indexed citations
16.
Bielinska, Anna U., Katarzyna Janczak, Jeffrey J. Landers, et al.. (2008). Nasal Immunization with a Recombinant HIV gp120 and Nanoemulsion Adjuvant Produces Th1 Polarized Responses and Neutralizing Antibodies to Primary HIV Type 1 Isolates. AIDS Research and Human Retroviruses. 24(2). 271–281. 68 indexed citations
17.
Makidon, Paul E., Anna U. Bielinska, Shraddha S. Nigavekar, et al.. (2008). Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine. PLoS ONE. 3(8). e2954–e2954. 117 indexed citations
18.
Myc, Andrzej, Thomas E. Vanhecke, Jeffrey J. Landers, Tarek Hamouda, & James R. Baker. (2003). The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi. Mycopathologia. 155(4). 195–201. 52 indexed citations
19.
Myc, Andrzej, Jolanta F. Kukowska‐Latallo, Anna U. Bielinska, et al.. (2003). Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion. Vaccine. 21(25-26). 3801–3814. 74 indexed citations
20.
Landers, Jeffrey J., Zhengyi Cao, Inhan Lee, et al.. (2002). Prevention of Influenza Pneumonitis by Sialic Acid–Conjugated Dendritic Polymers. The Journal of Infectious Diseases. 186(9). 1222–1230. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026